Literature DB >> 9269865

A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.

J K Li1, N Wang, X S Wu.   

Abstract

Gelatin nanoparticle-poly(lactic-co-glycolic acid) (PLGA) microsphere composites were prepared by encapsulating protein-loaded gelatin nanoparticles in PLGA microspheres. This encapsulation was conducted by using a phase separation method and a solvent extraction method. The average diameter of the gelatin nanoparticle-PLGA microsphere composites is between 160 and 175 microm. Protein loading efficiency is 93.2% for the nanoparticle-microsphere composite prepared by the phase separation method, while it is 31.31% for the composite prepared by the solvent extraction method. Protein release experiments indicate that this new composite system possesses sustained release characteristics. This system also demonstrates the capability of preventing the denaturation of protein drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269865     DOI: 10.1021/js970084i

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.

Authors:  B H Woo; G Jiang; Y W Jo; P P DeLuca
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 2.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

Review 3.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

4.  A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.

Authors:  N Wang; X S Wu; J K Li
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

5.  Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces.

Authors:  G J S Dawes; L E Fratila-Apachitei; B S Necula; I Apachitei; G J Witkamp; J Duszczyk
Journal:  J Mater Sci Mater Med       Date:  2009-08-11       Impact factor: 3.896

6.  Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.

Authors:  Ge Jiang; Wei Qiu; Patrick P DeLuca
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

7.  Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system.

Authors:  Tarun K Mandal; Levon A Bostanian; Richard A Graves; Sharlene R Chapman
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

8.  In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases.

Authors:  X Li; X Deng; Z Huang
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

9.  Prolonged release from PLGA/HAp scaffolds containing drug-loaded PLGA/gelatin composite microspheres.

Authors:  Gongwen Tang; Hong Zhang; Yunhui Zhao; Xiao Li; Xiaoyan Yuan; Min Wang
Journal:  J Mater Sci Mater Med       Date:  2011-11-18       Impact factor: 3.896

10.  Actin exposure upon tissue injury is a targetable wound site-specific protein marker.

Authors:  Erik D Pendleton; Challise J Sullivan; Henri H Sasmor; Kristy D Bruse; Tifanie B Mayfield; David L Valente; Rachel E Abrams; Richard H Griffey; John Dresios
Journal:  Biochem Biophys Rep       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.